Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects

被引:0
|
作者
Yong Zeng
Yi-jing He
Fu-yuan He
Lan Fan
Hong-hao Zhou
机构
[1] Pharmacogenetics Research Institute,
[2] Institute of Clinical Pharmacology,undefined
[3] Central South University,undefined
来源
Acta Pharmacologica Sinica | 2009年 / 30卷
关键词
bifendate; cyclosporine; pharmacokinetics; CYP3A4; 18B;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:478 / 484
页数:6
相关论文
共 50 条
  • [21] Drug-Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects
    Chen, Jin
    Stringer, Rowan
    Shah, Bharti
    Gu, Jessie
    Zhang, Yiming
    Hackling, Melissa
    Prince, William
    Woessner, Ralph
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (11): : 1253 - 1263
  • [22] Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects
    Hsyu, Poe-Hirr
    Pignataro, Daniela Soriano
    Matschke, Kyle
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (01) : 49 - 56
  • [23] Effect of CYP2B6 Genotype on the Pharmacokinetics of Sibutramine and Active Metabolites in Healthy Subjects
    Chung, Jae Yong
    Jang, Seong Bok
    Lee, Yoon Jung
    Park, Min Soo
    Park, Kyungsoo
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01) : 53 - 59
  • [24] Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects
    Poe-Hirr Hsyu
    Daniela Soriano Pignataro
    Kyle Matschke
    European Journal of Clinical Pharmacology, 2017, 73 : 49 - 56
  • [25] Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
    Abel, Samantha
    Russell, Deborah
    Taylor-Worth, Richard J.
    Ridgway, Caroline E.
    Muirhead, Gary J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 : 27 - 37
  • [26] Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects
    Jiaming Li
    Xiaoqian Wang
    Chen Ning
    Zhaoyu Wang
    Yao Wang
    Ming Zheng
    Siliang Zhang
    Yang Lu
    Yongjie Zhang
    Ning Li
    Xijing Chen
    Di Zhao
    European Journal of Clinical Pharmacology, 2020, 76 : 1125 - 1133
  • [27] Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects
    Li, Jiaming
    Wang, Xiaoqian
    Ning, Chen
    Wang, Zhaoyu
    Wang, Yao
    Zheng, Ming
    Zhang, Siliang
    Lu, Yang
    Zhang, Yongjie
    Li, Ning
    Chen, Xijing
    Zhao, Di
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (08) : 1125 - 1133
  • [28] Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients
    Moes, D. J. A. R.
    Swen, J. J.
    den Hartigh, J.
    van der Straaten, T.
    van der Heide, Homan J. J.
    Bemelman, F.
    de Fijter, J. W.
    Guchelaar, H. J.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 672 - 672
  • [29] Effect of CYP3A4*18B polymorphisms and interactions with OPRM1 A118G on postoperative fentanyl requirements in patients undergoing radical gastrectomy
    Liao, Qin
    Chen, Dao-Jin
    Zhang, Fan
    Li, Li
    Hu, Rong
    Tang, Yong-Zhong
    Ou-Yang, Wen
    Huang, Dong
    MOLECULAR MEDICINE REPORTS, 2013, 7 (03) : 901 - 908
  • [30] Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects
    Kim, Kyoung-Ah
    Park, Pil-Whan
    Lee, Ock-Je
    Kang, Dong-Kyun
    Park, Ji-Young
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (01) : 87 - 93